Home

JAMES NIEDEL

CIK 1231092 · last filed 2017-06-29

JAMES NIEDEL is a corporate insider who has filed 10 SEC Form 4 insider transactions across 3 companies since 2012. The most recent filing, for CMRX, was dated Jun 29, 2017. Across all open-market trades the lifetime net is +$31.4M, making them a net buyer over the disclosed history. 24 SEC filings were submitted jointly with Philippe O. Chambon.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

10

Lifetime Open-Market Net

$31.42M

Filer Profile

Reported Address
C/O CREDIT SUISSE PRIVATE EQUITY INC
11 MADISON AVE
NEW YORK, NY 10010
Related Filers
Philippe O. Chambon — 24 joint filings, latest 2014-10-01
Vijay K Lathi — 22 joint filings, latest 2014-10-01
Jeani Delagardelle — 20 joint filings, latest 2014-10-01
RONALD HUNT — 20 joint filings, latest 2014-10-01
New Leaf Venture Associates II, L.P. — 17 joint filings, latest 2014-10-01
New Leaf Venture Management II, L.L.C. — 17 joint filings, latest 2014-10-01
New Leaf Ventures II, L.P. — 17 joint filings, latest 2014-10-01
SRINIVAS AKKARAJU — 11 joint filings, latest 2013-02-20
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CHIMERIX INC (CMRX) Delisted Director 1,046,082 $8.54 $8.93M -$41.41M 7 2017-06-29
Relypsa Inc (RLYP) Delisted 1,924,626 — — $16.37M 1 2013-11-20
Durata Therapeutics, Inc. (DRTX) Delisted 10%+ Owner 2,244,126 — — $56.47M 1 2012-07-26

Recent Filings

10 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-06-29 CHIMERIX INC (CMRX) Delisted Grant (A) — $0 EDGAR
2016-06-28 CHIMERIX INC (CMRX) Delisted Grant (A) — $0 EDGAR
2015-06-24 CHIMERIX INC (CMRX) Delisted Grant (A) — $0 EDGAR
2014-09-11 CHIMERIX INC (CMRX) Delisted Mixed −497,312 -$27.96M EDGAR
2014-03-20 CHIMERIX INC (CMRX) Delisted Other (J) −700,000 $0 EDGAR
2013-11-20 Relypsa Inc (RLYP) Delisted Mixed +16,919,120 $16.37M EDGAR
2013-10-23 CHIMERIX INC (CMRX) Delisted Sell (S) −585,602 -$9.08M EDGAR
2013-04-16 CHIMERIX INC (CMRX) Delisted Conv (C) +2,410,551 $0 EDGAR
2012-07-26 Durata Therapeutics, Inc. (DRTX) Delisted Mixed +24,227,512 $56.47M EDGAR
2007-01-09 — Disp (D) −381,336 $0
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.